DEADLY FLU JAB WARNING: New flu vaccines make recipients 27 PERCENT MORE LIKELY to catch the flu
DEADLY FLU JAB WARNING: New flu vaccines make recipients 27 PERCENT MORE LIKELY to catch the flu
- Negative Vaccine Effectiveness: The 2024-2025 flu vaccine showed a -26.9% effectiveness rate, meaning vaccinated individuals had a 27% higher risk of contracting the flu compared to unvaccinated individuals. This suggests the vaccine may have impaired immunity rather than provided protection.
- Repeated Vaccination Risks: The study builds on prior research showing that annual flu vaccination may reduce effectiveness over time, with some past studies reporting negative efficacy (up to -54%) in multi-year recipients. Immune system interference and strain mismatches were cited as potential causes.
- Concerns Over Ingredients and Safety: Most participants received vaccines containing thimerosal (a mercury-based preservative linked to neurodevelopmental risks), which researchers speculated might weaken immune responses. Prior studies also associated flu vaccines with Guillain-Barré syndrome and non-flu respiratory infections.
- Challenge to Public Health Policies: Experts argue the findings contradict mainstream vaccine advocacy, highlighting flaws in mandates, lack of pre-release efficacy testing, and the impracticality of annual reformulations. The study calls for a reevaluation of blanket flu vaccination campaigns, especially given low mortality benefits (particularly in the elderly) and potential net harm.
This is deeply concerning folks. This year’s flu shots literally cause the jabbed sheeple to have a 27 percent higher risk of catching the flu. What kind of warped ‘medicine’ is this? The flu can be deadly, especially for people already suffering from cancer, diabetes, obesity, heart disease, lung disease, high blood pressure, and clot shot syndrome from the spike proteins of the Covid stabs.
A new preprint study of over 53,000 Cleveland Clinic employees suggests that the 2024-2025 influenza vaccine may have increased recipients’ risk of contracting the flu by 27%, contradicting long-standing public health recommendations. Published last week on MedRxiv, the research found a negative vaccine effectiveness rate of 26.9%, sparking debate among scientists and medical professionals. Conducted during a season marked by high flu transmission, the study challenges the effectiveness of annual vaccination campaigns—particularly when strain mismatches occur.
The study tracked vaccinated and unvaccinated employees from October 2023 to February 2024, revealing that flu infections rose more rapidly among those who received the shot. “The vaccine has not been effective in preventing influenza this season,” the authors concluded. Epidemiologist Nicolas Hulscher called the findings “deeply concerning,” while Dr. Clayton J. Baker stated the data “strongly suggests the shot was outright harmful.”
Internist Dr. Meryl Nass noted that flu vaccines are not rigorously tested for efficacy before approval, as they rely on historical licensing. “Negative efficacy is possible,” she said, citing minimal pre-release safety evaluations.
Massive contradictions are evident from the Medical Industrial Complex, the Vaccine Industrial Complex, and the Mass Media push for everyone to get flu jabs
Despite the Cleveland Clinic’s vaccine mandate for employees, the unvaccinated cohort—comprising those with medical or religious exemptions—showed lower infection rates. Karl Jablonowski of Children’s Health Defense argued the results expose flaws in mandates: “Those exempt posed less of a threat [to patients] than those who were mandated.”
The study echoes prior research, including a 2012 Clinical Infectious Diseases paper linking flu vaccines to higher rates of non-flu respiratory infections. James Lyons-Weiler, Ph.D., called the new analysis “one of the most consequential influenza vaccine studies in recent years” due to its scale and independence from industry funding.
Researchers suggested strain mismatch—a misalignment between the vaccine and circulating flu variants—may explain the poor performance. Lyons-Weiler added that thimerosal, a mercury-based preservative in 98.7% of administered doses, could weaken immune responses. Thimerosal has been tied to neurodevelopmental risks in earlier studies, raising further safety concerns.
CDC data shows declining flu vaccine uptake among healthcare workers, signaling growing skepticism. “Annual flu vaccine strategies may need a serious rethink,” wrote TrialSite News, urging policymakers to address evidence of potential harm.
The study’s implications extend beyond this flu season, challenging the foundation of mass vaccination campaigns. As Baker noted, “It may be asking for too much to expect [the vaccine] to be highly effective year after year.” With public trust in vaccines wavering, health officials face pressure to reevaluate blanket recommendations—and the science behind them.
Bookmark plague.info to your favorite independent websites for updates on new gain-of-function viruses the CDC and WHO release into the “wild” while they push deadly flu shots and clot shots on the masses.
Sources for this article include:
